An Artificial Intelligence Driven Approach to Optimize Patient Selection for a Transitional Pain Service
NCT07296770 is a phase 3 interventional trial sponsored by University of California, San Francisco. As of 18 Nov 2026, it is not yet recruiting. It studies Pharmacologic Pain Management in Opioid Use After Surgery, Postsurgical Pain Management and 1 more condition. The registry lists an enrollment of 474 participants at 1 site in 1 country. The registry lists a start date of 1 Oct 2026 and a primary completion date of 1 Dec 2028.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT07296770 |
| Status | Not yet recruiting |
| Phase | Phase 3 |
| Study type | Interventional trial |
| Lead sponsor | University of California, San Francisco |
| Enrollment | 474 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | Opioid Use After Surgery, Postsurgical Pain Management and Postsurgical Pain, Chronic |
| Drugs | Pharmacologic Pain Management |
| Start | 1 Oct 2026 |
| Primary completion | 1 Dec 2028 |
| Study completion | 1 Dec 2029 |
| Last update posted | 9 Oct 2026 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Andrew Bishara, MD
UCSF Department of Anesthesia
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ucsf Hospitals
San Francisco
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Questions about NCT07296770
Each answer restates registry values shown on this page.
What is NCT07296770?
NCT07296770 is a phase 3 interventional trial sponsored by University of California, San Francisco. It studies Pharmacologic Pain Management in Opioid Use After Surgery, Postsurgical Pain Management and 1 more condition.
Is NCT07296770 recruiting?
As of 18 Nov 2026, it is not yet recruiting.
Who leads NCT07296770?
The registry names Andrew Bishara, MD (principal investigator, UCSF Department of Anesthesia) as the overall official.
Where does NCT07296770 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
Which drugs does NCT07296770 study?
The registered drug and biological interventions are Pharmacologic Pain Management.
When is NCT07296770 expected to complete?
The registry lists a primary completion date of 1 Dec 2028 and a study completion date of 1 Dec 2029. The sponsor last updated the record on 9 Oct 2026.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.